← Back to Search

Analgesic

Acetaminophen for Post-Op Pain After Bariatric Surgery

Phase 2
Recruiting
Led By Daniel T Abazia, PharmD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults aged 18 years old or greater who meet patient selection criteria for either primary Roux-en-Y gastric bypass or primary laparoscopic sleeve gastrectomy.
Be older than 18 years old
Must not have
Medical exclusions: Patients with documented history of chronic and/or current pain syndrome, as evidenced by documentation of ICD-10 code G89.4, patients with documented ICD-10 code F11.90, indication unspecified, uncomplicated opioid use.
Surgical exclusions: Duodenal Switch (DS) surgeries, Adjustable Gastric Banding (AGB), surgical revisions, and surgical conversions.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from date of consent until the date of hospital discharge, assessed up to 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to understand how patients with morbid obesity who have undergone weight loss surgery metabolize acetaminophen (a common pain reliever). The study will compare how well the body absorbs and

Who is the study for?
This trial is for adults with morbid obesity who have undergone Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy. Participants should be in need of postoperative pain management and able to take oral medication. Specific details on inclusion and exclusion criteria are not provided.
What is being tested?
The study aims to compare the effectiveness of liquid versus pill forms of acetaminophen for managing post-op pain in bariatric surgery patients, considering their unique drug metabolism challenges.
What are the potential side effects?
While specific side effects are not listed, common ones associated with acetaminophen include nausea, allergic reactions, skin rash, and at high doses a risk of liver damage.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older and eligible for weight loss surgery.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have a chronic pain condition or a history of opioid use.
Select...
I have not had weight loss surgeries like DS, AGB, or any surgical revisions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from date of consent until the date of hospital discharge, assessed up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and from date of consent until the date of hospital discharge, assessed up to 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pain control
Secondary study objectives
Length of stay (LOS)
Milligrams Morphine Equivalents (MME)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Oral acetaminophen - TabletExperimental Treatment1 Intervention
Acetaminophen 650 mg tablet by mouth
Group II: Oral acetaminophen - LiquidExperimental Treatment1 Intervention
Acetaminophen 650 mg liquid by mouth
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acetaminophen
2017
Completed Phase 4
~2030

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
455 Previous Clinical Trials
69,801 Total Patients Enrolled
Rutgers Robert Wood Johnson Medical SchoolOTHER
6 Previous Clinical Trials
17,812 Total Patients Enrolled
Daniel T Abazia, PharmDPrincipal InvestigatorRutgers University - Ernest Mario School of Pharmacy
~75 spots leftby Feb 2025